These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34403195)

  • 21. An RNA-dependent and phase-separated active subnuclear compartment safeguards repressive chromatin domains.
    Lerra L; Panatta M; Bär D; Zanini I; Tan JY; Pisano A; Mungo C; Baroux C; Panse VG; Marques AC; Santoro R
    Mol Cell; 2024 May; 84(9):1667-1683.e10. PubMed ID: 38599210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer.
    Guzel E; Karatas OF; Duz MB; Solak M; Ittmann M; Ozen M
    Prostate; 2014 Nov; 74(15):1498-505. PubMed ID: 25175483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into prostate cancer stem cells.
    Chen X; Rycaj K; Liu X; Tang DG
    Cell Cycle; 2013 Feb; 12(4):579-86. PubMed ID: 23370446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromodomain (BrD) Family Members as Regulators of Cancer Stemness-A Comprehensive Review.
    Czerwinska P; Mackiewicz AA
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The phytochemical 3,3'-diindolylmethane decreases expression of AR-controlled DNA damage repair genes through repressive chromatin modifications and is associated with DNA damage in prostate cancer cells.
    Palomera-Sanchez Z; Watson GW; Wong CP; Beaver LM; Williams DE; Dashwood RH; Ho E
    J Nutr Biochem; 2017 Sep; 47():113-119. PubMed ID: 28582660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ecotropic viral integration site 1, a novel oncogene in prostate cancer.
    Queisser A; Hagedorn S; Wang H; Schaefer T; Konantz M; Alavi S; Deng M; Vogel W; von Mässenhausen A; Kristiansen G; Duensing S; Kirfel J; Lengerke C; Perner S
    Oncogene; 2017 Mar; 36(11):1573-1584. PubMed ID: 27617580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
    Liu R; Liu C; Zhang D; Liu B; Chen X; Rycaj K; Jeter C; Calhoun-Davis T; Li Y; Yang T; Wang J; Tang DG
    Oncotarget; 2016 Aug; 7(35):56628-56642. PubMed ID: 27447749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of microRNA‑574 in cancer stem cells causes recurrence of prostate cancer via targeting REL.
    Lai X; Guo Y; Guo Z; Liu R; Wang X; Wang F
    Oncol Rep; 2016 Dec; 36(6):3651-3656. PubMed ID: 27779701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A
    J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties.
    Yadav S; Kowolik CM; Lin M; Zuro D; Hui SK; Riggs AD; Horne DA
    Mol Carcinog; 2019 Jan; 58(1):113-125. PubMed ID: 30242889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SPOP and CHD1 alterations in prostate cancer: Relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence.
    Hernández-Llodrà S; Segalés L; Juanpere N; Marta Lorenzo T; Salido M; Nonell L; David López T; Rodríguez-Vida A; Bellmunt J; Fumadó L; Cecchini L; Lloreta-Trull J
    Prostate; 2021 Dec; 81(16):1267-1277. PubMed ID: 34533858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1.
    Hu J; Sun F; Chen W; Zhang J; Zhang T; Qi M; Feng T; Liu H; Li X; Xing Y; Xiong X; Shi B; Zhou G; Han B
    J Exp Clin Cancer Res; 2019 May; 38(1):227. PubMed ID: 31138311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53-dependent CD51 expression contributes to characteristics of cancer stem cells in prostate cancer.
    Sui X; Cai J; Li H; He C; Zhou C; Dong Y; Chen L; Zhang B; Wang Y; Zhang Y; Qiu Y; Zhang Y; Zhao Y; Huang Y; Shen Y; Wu H; Xiao J; Mason C; Zhu Q; Han S
    Cell Death Dis; 2018 May; 9(5):523. PubMed ID: 29743605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.
    Chen P; Chaikuad A; Bamborough P; Bantscheff M; Bountra C; Chung CW; Fedorov O; Grandi P; Jung D; Lesniak R; Lindon M; Müller S; Philpott M; Prinjha R; Rogers C; Selenski C; Tallant C; Werner T; Willson TM; Knapp S; Drewry DH
    J Med Chem; 2016 Feb; 59(4):1410-24. PubMed ID: 25799074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.
    Yang DR; Ding XF; Luo J; Shan YX; Wang R; Lin SJ; Li G; Huang CK; Zhu J; Chen Y; Lee SO; Chang C
    J Biol Chem; 2013 Jun; 288(23):16476-16483. PubMed ID: 23609451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
    Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
    Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of lncRNAs in prostate cancer development and progression.
    Weiss M; Plass C; Gerhauser C
    Biol Chem; 2014 Nov; 395(11):1275-90. PubMed ID: 25153594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer.
    Hsu CC; Shi J; Yuan C; Zhao D; Jiang S; Lyu J; Wang X; Li H; Wen H; Li W; Shi X
    Genes Dev; 2018 Jan; 32(1):58-69. PubMed ID: 29437725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LINC00885 promotes cervical cancer progression through sponging miR-3150b-3p and upregulating BAZ2A.
    Liu Y; Chen J; Zhou L; Yin C
    Biol Direct; 2022 Jan; 17(1):4. PubMed ID: 35012615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bromodomain-containing proteins in prostate cancer.
    Urbanucci A; Mills IG
    Mol Cell Endocrinol; 2018 Feb; 462(Pt A):31-40. PubMed ID: 28624514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.